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Objective: Renal ischemia/reperfusion rapidly elevates the protein-bound
uremic toxin, indoxyl sulfate, and promotes the activation of the renin-
angiotenisin system (RAS). We examined the protective effects of RAS
blockers by attenuating the loss of angiotensin-converting enzyme 2
(ACE2) and its product, angiotensin 1e7 (Ang 1e7), in experimental model
of acute kidney injury and indoxyl sulfate.
Methods: When human proximal tubular epithelial cell lines (HK-2)
underwent the management of indoxyl sulfate in the association with
hypoxia, the RAS components including angiotensinogen and ACE were up-
regulated other than the ACE2. The imbalance of cellular ACE/ACE2 ratio
induced reactive oxygen species (ROS), activated Erk, and inhibited AMPK,
but these events were reversed by aliskiren and losartan.
Results: In IS-treated AKI mice, the inflammation, fibrosis, epithelial
mesenchymal transition, dedifferentiation and ROS were alleviated in
RAS blockers by reestablishment of the expression of ACE2. Moreover,
both of them could improve the level of Ang1e7 and reduce the level of
8-hydroxy-2’-deoxyguanosine in patients with hyperreninemic
hypertension.
Conclusion: These findings suggested that RAS blockers possessed anti-
oxidative activity to ameliorate the IS-induced renal damage, which may
be partly attributed to modulation of ROS/ERK and ROS/AMPK pathways as
well as downstream ACE2/Ang1e7 axis.http://dx.doi.org/10.1016/j.hkjn.2015.09.0490011
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Background: Transient receptor potential melastatin 7 (TRPM7) is multi-func-
tion ionchannelandkinase.Thenovelcyclic helixBpeptide (CHBP), erythropoi-
etin derivative, improves renal ischemia reperfusion injury (IRI). Here, the role
and mechanism of TRPM7 in IRI and CHBP renoprotection were investigated.
Methods: TRPM7 mRNA and protein, apoptosis, inflammation, renal function
and structure were measured in TCMK1 cells and mouse kidneys subjected to
12-h hypoxia (H)/30-min ischemia followed by reoxygenation (R) at different
time points. 2-APB (TRPM7 inhibitor) and CHBP were also applied in HR cells
and/or IRI kidneys. The correlations between TRPM7 and other injury param-
eters were analysed.
Results: TRPM7 mRNA and protein were increased in the TCMK1 cells exposed
to 12 and 24-h R, while TRPM7 protein was also increased by 42%, 35% and 30%
in IRI kidneys at 12 and 24 h, and 7 d. Increased apoptotic cells were reduced
65% by 2-APB in TCMK1 cells post HR, while LDH in supernatant and HMGB1 in
TCMK1 cells were also increased. Further more, CHBP reduced TRPM7 in HR
TCMK1 cells, as well as IRI kidneys. TRPM7 was significantly correlated with
LDH and HMGB1; and serum creatinine, blood urea nitrogen, inflammation,
apoptosis and tubulointerstitial damage in these in vitro and/or in vivomodels.
Conclusion: TRPM7 is involved in renal IR-related injuries and CHBP renopro-
tection, which might be a biomarker for diagnosis and intervention.http://dx.doi.org/10.1016/j.hkjn.2015.09.050
